Full Event Guide
Highlights of the Full Event Guide include:
- Evaluate the current state of play for TGF-beta in Immuno-oncology Drug development
- Explore MOA and Biomarker development. Assess the right preclinical models to represent the TME and Immune-relate toxicity
- Discover novel approaches to inhibit TGF-beta, though integrin inhibition, antisense agents, integration with CAR-T and more
- Data Debrief: Hear the latest efficacy data from the most advanced TGF-beta clinical candidates
This online platform allows not only remote presentations but also live Q&A, live breakout discussions among delegates, 1-2-1 chatting between individuals, a virtual exhibition space and other networking features.